Sign in

CIK 0002022626

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Upstream Bio, Inc.

Sign in to watch
Ticker
UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-208-2466
Business address
890 WINTER STREET, SUITE 200, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$27,604
in 5 filings

Net −$27,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-09 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +17,096 17,096
2025-06-10 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +17,096 17,096
2024-10-10 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +17,096 17,096

Page 1 of 1 · 3 trades